Article citationsMore>>
Koizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., Toh, Y., Nagaie, T., Takagi, S., Yamamura, Y., Yanaoka, K., Orita, H. and Takeuchi, M. (2008) S-1 plus Cisplatin versus S-1 Alone for First-Line Treatment of Advanced Gastric Cancer (SPIRITS trial): A Phase III Trial. The Lancet Oncology, 9, 215-221.
http://dx.doi.org/10.1016/S1470-2045(08)70035-4
has been cited by the following article:
-
TITLE:
Effect of Fucoidan Dietary Supplement on the Chemotherapy Treatment of Patients with Unresectable Advanced Gastric Cancer
AUTHORS:
Masahide Ikeguchi, Hiroaki Saito, Yasunari Miki, Takayuki Kimura
KEYWORDS:
Chemotherapy, Fucoidan, Gastric Cancer, Toxicity, Prognosis
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.6 No.11,
October
30,
2015
ABSTRACT: In Japan, S-1 plus cisplatin has become a standard regimen for the
treatment of unresectable advanced gastric cancer; however, many patients are
unable to continue effective chemotherapy because of the regimen’s severe side
effects. Thus, control of drug toxicity is key to prolonging patient survival.
Fucoidan is a major sulfated polysaccharide found in brown seaweeds and has a
wide range of biological activities. In the present study, we analyzed the
effect of fucoidan on suppressing the toxicity of chemotherapy drugs.
Twenty-four patients with unresectable advanced gastric cancer underwent
treatment with S-1 plus cisplatin and were randomly allocated into a fucoidan
treatment group (n = 12) or a control group without fucoidan treatment (n =
12). The study results demonstrated that fucoidan controlled the occurrence of
fatigue during chemotherapy and patients could continue chemotherapy for longer
time periods by maintaining the patients’ favorable nourishment status. As a
result, the survival of patients with fucoidan treatment was longer than that
of patients without fucoidan. Thus, fucoidan should be included as a key food
supplement for patients with gastrointestinal carcinomas who are suffering from
the adverse side effects of chemotherapy.
Related Articles:
-
Giancarlo T. Tomezzoli
-
Hironaga Satake, Akihito Tsuji, Takeshi Kotake, Mikio Fujita
-
Sopita Khamrod
-
R. Douglas Martin, Shengyu Zhang
-
Yasutake Uchima, Naoki Aomatsu, Gen Tsujio, Takehiko Iwauchi, Shinji Matsutani, Hiroto Tanaka, Hironari Miyamoto, Takuma Okada, Shigeaki Kurihara, Toshiki Hirakawa, Keiichiro Hirata, Junya Morimoto, Shigehito Yamagata, Kazuhiro Takeuchi